Lymphocytes, neuropeptides, and genes involved in alopecia areata

Journal of Clinical Investigation

Volumn 117, Issue 8, 2007, Pages 2019-2027

  Gilhar, Amos ^a   Paus, Ralf ^b   Kalish, Richard S ^c,d  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c STONY BROOK UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE;

ALOPECIA AREATA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; HAIR FOLLICLE; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ALOPECIA AREATA; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HAIR FOLLICLE; HLA ANTIGENS; HUMANS; INFLAMMATION; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; ORGAN SPECIFICITY; T-LYMPHOCYTES;

EID: 34547687736     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31942     Document Type: Review

References (101)

1. Safavi, K.H., Muller, S.A., Suman, V.J., Moshell, A.N., and Melton, L.J., 3rd. 1995. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin. Proc. 70:628-633.
2. Paus, R., Nickoloff, B.J., and Ito, T. 2005. A "hairy" privilege. Trends Immunol. 26:32-40.
3. Gilhar, A., and Kalish, R.S. 2006. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun. Rev. 5:64-69.
4. Gilhar, A., Ullmann, Y., Berkutzki, T., Assy, B., and Kalish, R.S. 1998. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J. Clin. Invest. 101:62-67.
5. Sundberg, J.P., and King, L.E., Jr. 2003. Mouse alopecia areata models: an array of data on mechanisms and genetics. J. Investig. Dermatol. Symp. Proc. 8:173-175.
6. Freyschmidt-Paul, P., et al. 2006. Interferon-gamma deficient mice are resistant to the development of alopecia areata. Br. J. Dermatol. 155:515-521.
7. Ito, T., et al. 2005. Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J. Invest. Dermatol. 125:1139-1148.
8. Wasserman, D., Guzman-Sanchez, D.A., Scott, K., and McMichael, A. 2007. Alopecia areata. Int. J. Dermatol. 46:121-131.
9. Plinck, E.P., Peereboom-Wynia, J.D., Vuzevski, V.D., Westerhof, W., and Stolz, E. 1993. Turning white overnight, is it possible? [In Dutch]. Ned. Tijdschr. Geneeskd. 137:1207-1210.
10. McDonagh, A.J., and Messenger, A.G. 1996. The pathogenesis of alopecia areata. Dermatol. Clin. 14:661-670.
11. Paus, R., Slominski, A., and Czarnetzki, B.M. 1994. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J. Biol. Med. 66:541-554.
12. Tan, E., Tay, Y.K., Goh, C.L., and Chin Giam, Y. 2002. The pattern and profile of alopecia areata in Singapore - a study of 219 Asians. Int. J. Dermatol. 41:748-753.
13. Tosti, A., Bellavista, S., and Iorizzo, M. 2006. Alopecia areata: a long term follow-up study of 191 patients. J. Am. Acad. Dermatol. 55:438-441.
14. Yang, S., et al. 2004. The genetic epidemiology of alopecia areata in China. Br. J. Dermatol. 151:16-23.
15. Sladden, M.J., MacDonald Hull, S.P., Wood, M.L., Hutchinson, P.E., and Messenger, A.G. 2005. Alopecia areata: the need for guidelines and evidence-based dermatology. Br. J. Dermatol. 152:1086-1087.
16. Happle, R. 2002. Diphencyprone for the treatment of alopecia areata: more data and new aspects. Arch. Dermatol. 138:112-123.
17. Cotellessa, C., Peris, K., Caracciolo, E., Mordenti, C., and Chimenti, S. 2001. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J. Am. Acad. Dermatol. 44:73-76.
18. Hoffmann, R., et al. 1996. Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Acta Derm. Venereol. 76:17-20.
19. Gupta, P., et al. 2006. A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata. J. Invest. Dermatol. 126:1559-1573.
20. Sperling, L.C., and Lupton, G.P. 1995. Histopathology of nonscarring alopecia. J. Cutan. Pathol. 22:97-114.
21. Todes-Taylor, N., Turner, R., Wood, G.S., Stratte, P.T., and Morhenn, V.B. 1984. T cell subpopulations in alopecia areata. J. Am. Acad. Dermatol. 11:216-223.
22. Whiting, D.A. 2003. Histopathologic features of alopecia areata: a new look. Arch. Dermatol. 139:1555-1559.
23. Ying, J., et al. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356:1216-1225.
24. Sonderstrup, G., and McDevitt, H.O. 2001. DR, DQ, and you: MHC alleles and autoimmunity. J. Clin. Invest. 107:795-796.
25. McDonagh, A.J., and Tazi-Ahnini, R. 2002. Epidemiology and genetics of alopecia areata. Clin. Exp. Dermatol. 27:405-409.
26. Colombe, B.W., Price, V.H., Khoury, E.L., Garovoy, M.R., and Lou, C.D. 1995. HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol. 33:757-764.
27. de Andrade, M., et al. 1999. Alopecia areata in families: association with the HLA locus. J. Investig. Dermatol. Symp. Proc. 4:220-223.
28. Marques Da Costa, C., et al. 2006. Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients. Dermatology. 213:12-14.
29. Colombe, B.W., Lou, C.D., and Price, V.H. 1999. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J. Investig. Dermatol. Symp. Proc. 4:216-219.
30. Akar, A., Orkunoglu, E., Sengul, A., Ozata, M., and Gur, A.R. 2002. HLA class II alleles in patients with alopecia areata. Eur. J. Dermatol. 12:236-239.
31. Xiao, F.L., et al. 2005. Association of HLA-DQA1 and DQB1 alleles with alolpecia areata in Chinese Hans. Arch. Dermatol. Res. 297:201-209.
32. Xiao, F.L., et al. 2006. Association of HLA class I alleles with aloplecia areata in Chinese Hans. J. Dermatol. Sci. 41:109-119.
33. Duvic, M., et al. 1991. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. Arch. Dermatol. 127:64-68.
34. Broniarczyk-Dyla, G., et al. 2002. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata. Arch. Immunol. Ther. Exp. (Warsz.). 50:333-336.
35. Barahmani, N., de Andrade, M., Slusser, J.P., Zhang, Q., and Duvic, M. 2006. Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126:74-78.
36. Ito, T., Saathoff, M., Nickoloff, B.J., Takigawa, M., and Paus, R. 2005. Novel aspects of hair follicle immune privilege and their relevance to alopecia areata [abstract]. J. Invest. Dermatol. 124(Suppl.):A103.
37. Schepis, C., Barone, C., Siragusa, M., Pettinato, R., and Romano, C. 2002. An updated survey on skin conditions in Down syndrome. Dermatology. 205:234-238.
38. Tazi-Ahnini, R., et al. 2002. Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens. 60:489-495.
39. Buzi, F., et al. 2003. Autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy syndrome: time to review diagnostic criteria? J. Clin. Endocrinol. Metab. 88:3146-3148.
40. Collins, S.M., Dominguez, M., Ilmarinen, T., Costigan, C., and Irvine, A.D. 2006. Dermatological manifestations of autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy syndrome. Br. J. Dermatol. 154:1088-1093.
41. Pforr, J., et al. 2006. Investigation of the p.Ser278Arg polymorphism of the autoimmune regulator (AIRE) gene in alopecia areata. Tissue Antigens. 68:58-61.
42. Kemp, E.H., et al. 2006. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum. Immunol. 67:535-539.
43. Tazi-Ahnini, R., et al. 2002. Genetic analysis of the interleukin1 receptor antagonist and its homologue IL1L1 in alopecia areata: strong severity association and possible gene interaction. Eur. J. Immunogenet. 29:25-30.
44. Shimizu, T., et al. 2005. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun. 6:285-289.
45. Tazi-Ahnini, R., et al. 2003. Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum. Genet. 112:400-403.
46. Martinez-Mir, A., et al. 2007. Genomewide scan for linkage reveals evidence of several susceptibility Loci for alopecia areata. Am. J. Hum. Genet. 80:316-328.
47. Duvic, M., Norris, D., Christiano, A., Hordinsky, M., and Price, V. 2003. Alopecia areata registry: an overview. J. Investig. Dermatol. Symp. Proc. 8:219-221.
48. Sundberg, J.P., Silva, K.A., Li, R., Cox, G.A., and King, L.E. 2004. Adult-onset alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J. Invest. Dermatol. 123:294-297.
49. Gilhar, A., and Krueger, G.G. 1987. Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice. Arch. Dermatol. 123:44-50.
50. Tobin, D.J., Hann, S.K., Song, M.S., and Bystryn, J.C. 1997. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch. Dermatol. 133:57-61.
51. Tobin, D.J. 2003. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J. Investig. Dermatol. Symp. Proc. 8:176-181.
52. Okamoto, M., et al. 2004. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J. Autoimmun. 23:257-266.
53. Gilhar, A., Pillar, T., Assy, B., and David, M. 1992. Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice. Br. J. Dermatol. 126:166-171.
54. Harrist, T.J., Ruiter, D.J., Mihm, M.C., and Bhan, A.K. 1983. Distribution of major histocompatibility antigens in normal skin. Br. J. Dermatol. 109:623-633.
55. Paus, R., et al. 1998. Generation and cyclic remodeling of the hair follicle immune system in mice. J. Invest. Dermatol. 111:7-18.
56. Christoph, T., et al. 2000. The human hair follicle immune system: cellular composition and immune privilege. Br. J. Dermatol. 142:862-873.
57. Paus, R., Christoph, T., and Muller-Rover, S. 1999. Immunology of the hair follicle: a short journey into terra incognita. J. Investig. Dermatol. Symp. Proc. 4:226-234.
58. Niederkorn, J.Y. 2006. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7:354-359.
59. Cobbold, S.P., et al. 2006. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev. 213:239-355.
60. Simpson, E. 2006. A historical perspective on immunological privilege. Immunol. Rev. 213:12-22.
61. Wahl, S.M., Wen, J., and Moutsopoulos, N. 2006. TGF-beta: a mobile purveyor of immune privilege. Immunol. Rev. 213:213-227.
62. Waldmann, H. 2006. Immunology: protection and privilege. Nature. 442:987-988.
63. Billingham, R.E., and Silvers, W.K. 1971. A biologist's reflections on dermatology. J. Invest. Dermatol. 57:227-240.
64. Ito, T., et al. 2004. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am. J. Pathol. 164:623-634.
65. Gilhar, A., Shalaginov, R., Assy, B., Serafimovich, S., and Kalish, R.S. 1999. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J. Investig. Dermatol. Symp. Proc. 4:207-210.
66. Gilhar, A., et al. 2003. Transfer of alopecia areata in the human scalp graft/Prkdcscid (SCID) mouse system is characterized by a TH1 response. Clin. Immunol. 106:181-187.
67. Gilhar, A., et al. 2002. Alopecia areata is mediated by cooperation between CD4+ and CD8+ T-lymphocytes: transfer to human scalp explants on Prkdcscid mice. Arch. Dermatol. 138:916-922.
68. Tobin, D.J., Fenton, D.A., and Kendall, M.D. 1990. Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J. Invest. Dermatol. 94:803-807.
69. Khoury, E.L., and Price, V.H. 1995. No cell-surface-reactive antibodies against cultured autologous melanocytes found in alopecia areata sera. J. Invest. Dermatol. 104(5 Suppl.):24S-25S.
70. Gilhar, A., et al. 2001. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J. Invest. Dermatol. 117:1357-1362.
71. McElwee, K.J., Boggess, D., King, L.E., Jr., and Sundberg, J.P. 1998. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J. Invest. Dermatol. 111:797-803.
72. McElwee, K.J., et al. 2002. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J. Invest. Dermatol. 119:1426- 1433.
73. Michie, H.J., Jahoda, C.A., Oliver, R.F., and Johnson, B.E. 1991. The DEBR rat: an animal model of human alopecia areata. Br. J. Dermatol. 125:94-100.
74. Oliver, R.F., and Lowe, J.G. 1995. Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata. Clin. Exp. Dermatol. 20:127-131.
75. McElwee, K.J., Pickett, P., and Oliver, R.F. 1996. The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br. J. Dermatol. 134:55-63.
76. McElwee, K.J., Spiers, E.M., and Oliver, R.F. 1999. Partial restoration of hair growth in the DEBR model for alopecia areata after in vivo depletion of CD4+ T cells. Br. J. Dermatol. 140:432-437.
77. Freyschmidt-Paul, P., et al. 2000. Treatment with an anti-CD44v10- specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J. Invest. Dermatol. 115:653-657.
78. Bodemer, C., et al. 2000. Role of cytotoxic T cells in chronic alopecia areata. J. Invest. Dermatol. 114:112-116.
79. Freyschmidt-Paul, P., et al. 2003. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J. Investig. Dermatol. Symp. Proc. 8:104-108.
80. Sugiyama, H., et al. 2005. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174:164-173.
81. Viglietta, V., Baecher-Allan, C., Weiner, H.L., and Hafler, D.A. 2004. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971-979.
82. Kriegel, M.A., et al. 2004. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199:1285-1291.
83. Zöller, M., McElwee, K.J., Engel, P., and Hoffmann, R. 2002. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J. Invest. Dermatol. 118:983-992.
84. Carroll, J.M., McElwee, K.J., King, L.E., Byrne, M.C., and Sundberg, J.P. 2002. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J. Invest. Dermatol. 119:392-402.
85. Gilhar, A., Etzioni, A., Assy, B., and Eidelman, S. 1993. Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma. Clin. Immunol. Immunopathol. 66:120-126.
86. Konig, A., Happle, R., and Hoffmann, R. 1997. IFN-gamma-induced HLA-DR but not ICAM-1 expression on cultured dermal papilla cells is downregulated by TNF-alpha. Arch. Dermatol. Res. 289:466-470.
87. Ruckert, R., Hofmann, U., van der Veen, C., Bulfone-Paus, S., and Paus, R. 1998. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J. Invest. Dermatol. 111:25-30.
88. Freyschmidt-Paul, P., et al. 2005. Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. J. Invest. Dermatol. 125:945-951.
89. Ito, T., et al. 2005. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br. J. Dermatol. 152:623-631.
90. Gilhar, A., Kam, Y., Assy, B., and Kalish, R.S. 2005. Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J. Invest. Dermatol. 124:288-289.
91. Paus, R., Theoharides, T.C., and Arck, P.C. 2006. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol. 27:32-39.
92. Peters, E.M., Arck, P.C., and Paus, R. 2006. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp. Dermatol. 15:1-13.
93. Arck, P.C., et al. 2005. Mast cell deficient and neurokinin1 receptor knockout mice are protected from stress-induced hair growth inhibition. J. Mol. Med. 83:386-396.
94. Arck, P.C., Slominski, A., Theoharides, T.C., Peters, E.M., and Paus, R. 2006. Neuroimmunology of stress: skin takes center stage. J. Invest. Dermatol. 126:1697-1704.
95. Peters, E.M., et al. 2004. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am. J. Pathol. 165:259-271.
96. Peters, E.M., et al. 2006. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J. Invest. Dermatol. 126:1937-1947.
97. Peters, E.M., et al. 2007. An in vitro model for the exploration of cutaneous stress responses: substance P inhibits hair growth, induces mast cell degranulation, up-regulates p75NTR expression and causes immune privilege collapse in vitro [abstract]. J. Invest. Dermatol. 127(Suppl. 1):S109.
98. Siebenhaar, F., et al. 2007. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J. Invest. Dermatol. 127:1489-1497.
99. Hordinsky, M.K., Kennedy, W., Wendelschafer-Crabb, G., and Lewis, S. 1995. Structure and function of cutaneous nerves in alopecia areata. J. Invest. Dermatol. 104(5 Suppl.):28S-29S.
100. Tang, L., Cao, L., Sundberg, J.P., Lui, H., and Shapiro, J. 2004. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp. Dermatol. 13:5-10.
101. Tang, L., Lui, H., Sundberg, J.P., Bissonnette, R., McLean, D.I., and Shapiro, J. 2003. Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J. Am. Acad. Dermatol. 49:1013-1019.